Some central European international locations together with Poland are keen to hurry up their vaccination programmes following procurement delays, in some instances adopting a much less cautious perspective than international locations comparable to Denmark.
On Monday Denmark turned the primary nation to exclude J&J’s vaccine. Final month it additionally stopped utilizing AstraZeneca’s vaccine citing comparable issues.
Polish authorities say the dangers of delaying the vaccination programme outweigh any dangers related to the pictures.
“Poland expressed such a willingness (to purchase up the J&J pictures)… The prime minister despatched a letter to the prime minister of Denmark as regards to these vaccines allowed to be used on the European market,” spokesman Piotr Muller informed Reuters by phone, confirming a report from Polsat Information.
Muller added that Poland was prepared to purchase any vaccines authorised to be used within the European Union, together with AstraZeneca.
Earlier, Polsat had quoted Polish Prime Minister Mateusz Morawiecki as saying in his letter to his Danish counterpart: “If Denmark decides to resell a few of its shares (of J&J pictures), Poland is able to purchase these vaccines.”
The workplace of Denmark’s Prime Minister was not instantly capable of touch upon the matter.
Europe’s drug regulator stated on April 20 it had discovered a doable hyperlink between J&J’s vaccine and uncommon blood clotting points in adults who acquired doses in the US. However it backed the vaccine’s total advantages towards any dangers.
Poland, the most important nation within the European Union’s japanese wing, has thus far totally vaccinated over 3.1 million folks out of a inhabitants of round 38 million.